Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Metadata
Title
Diet in the epidemiology of endometrial cancer in Western New York (United States)
Authors
Susan E. McCann
Jo L. Freudenheim
James R. Marshall
John R. Brasure
Mya K. Swanson
Saxon Graham
Publication date
01-12-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 10/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1026551309873

Other articles of this Issue 10/2000

Cancer Causes & Control 10/2000 Go to the issue

OriginalPaper

Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case–control studies in European countries

Legacy

Does biliary reflux of polycyclic aromatic hydrocarbons increase pancreatic cancer risk in smokers?

OriginalPaper

Reproductive and hormonal factors associated with mammographic breast density by age (United States)

OriginalPaper

Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland)

OriginalPaper

Bowel movement, use of laxatives and risk of colorectal adenomatous polyps among women (United States)

OriginalPaper

Association of basal cell skin cancers with other cancers (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits